CANIFERON
Live / Registered — Registered (as of 31 Jan 2023)
What this means for you
Registered since 31 Jan 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Jan 2029: the §71 affidavit of use).
Record
- Serial number
- 79327653
- Registration number
- 6966132
- Mark type
- Word mark
- Filed
- 16 Sept 2021
- Published for opposition
- 15 Nov 2022
- Registered
- 31 Jan 2023
- Next maintenance filing
- §71 affidavit of use, due by 31 Jan 2029 (grace period to 31 Jul 2029)
- Attorney of record
- Brian M. Davis
Goods and services
- Class 005 — Pharmaceuticals: [ Pharmaceuticals, medical and veterinary preparations for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of skin diseases; pharmaceutical, medical and veterinary preparations for dermatitis; pharmaceutical, medical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancer, skin disorders and inflammatory diseases; pharmaceutical, medical and ] veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases, * pruritic conditions, coronavirus and allergies * [ and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases, for animals; pharmaceutical, medical and veterinary drugs for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biological preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological reagents being pharmaceutical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological tissue cultures for medical use; biochemical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; anti-viral agents; diagnostic preparations for medical and veterinary purposes; clinical diagnostic reagents for medical and veterinary purposes; immunoassay reagents for medical use ]
Owner
Prosecution history
- 21 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 May 2025 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 01 May 2025 — LIMITATION FROM THE IB EXAMINED AND ENTERED
- 24 Apr 2025 — CORRECTION UNDER SECTION 7 - PROCESSED
- 24 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Oct 2024 — LIMITATION OF GOODS RECEIVED FROM IB
- 30 May 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 05 May 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 05 May 2023 — FINAL DISPOSITION PROCESSED
- 30 Apr 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2022 — ASSIGNED TO EXAMINER
- 15 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Nov 2022 — PUBLISHED FOR OPPOSITION